<DOC>
	<DOCNO>NCT01259622</DOCNO>
	<brief_summary>The purpose study evaluate effect single intravenous infusion K201 compare placebo dose escalate manner conversion sinus rhythm , reduction subject 's symptom score , safety .</brief_summary>
	<brief_title>Effects Intravenous K201 Restoration Sinus Rhythm Subjects With Symptomatic Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Symptomatic atrial fibrillation 3 hour less 7 day ( dated symptom ) . Atrial fibrillation document ECG start study drug infusion . Previous exposure K201 QTcF ( Fridericia correction ) &gt; 440 m QRS interval &gt; 140 m Paced atrial pace ventricular rhythm ECG History receive another intravenous Class I Class III antiarrhythmic drug within 3 day randomization History amiodarone ( oral IV ) last 3 month . Clinical evidence history acute coronary syndrome ( e.g . myocardial infarction , unstable angina ) within 30 day prior randomization History fail electrical cardioversion time past History polymorphic ventricular tachycardia ( e.g . torsades de pointes ) History family history Long QT Syndrome History ventricular tachycardia require drug device therapy Ejection fraction 40 % less .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>